These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3858980)

  • 1. Density distribution of chronic myeloid leukaemia and normal colony-forming cells in diffusion chambers (CFU-D) and agar (CFU-GM).
    Nilsson B; Olofsson T
    Scand J Haematol; 1985 Apr; 34(4):317-22. PubMed ID: 3858980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective recloning capacity of granulocyte-macrophage colony-forming cells in chronic myeloid leukaemia.
    Olofsson T; Nilsson B
    Scand J Haematol; 1986 Feb; 36(2):168-75. PubMed ID: 3458293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colony-forming units in diffusion chambers (CFU-d) and colony-forming units in agar culture (CFU-c) obtained from normal human bone marrow: a possible parent-progeny relationship.
    Jacobsen N; Broxmeyer HE; Grossbard E; Moore MA
    Cell Tissue Kinet; 1979 Mar; 12(2):213-26. PubMed ID: 371815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of granulocyte-committed progenitors from patients with chronic myeloid leukemia to humoral regulators release by macrophages in agar diffusion chamber culture.
    Hansz J; Sawiński K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(3):415-23. PubMed ID: 2414171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E1.
    Aglietta M; Piacibello W; Gavosto F
    Cancer Res; 1980 Jul; 40(7):2507-11. PubMed ID: 6930323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
    Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
    J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cells forming colonies in diffusion chambers in vivo (CFU-D) and cells with high proliferative potential in vitro (HPP-CFC-1 and -2).
    Niskanen E; Quesenberry PJ; Shellem TA; McNiece I
    Exp Hematol; 1990 May; 18(4):294-8. PubMed ID: 2323364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of haemopoietic progenitor cells from patients with chronic granulocytic leukaemia using percoll density gradients and elutriation.
    Martin H; Hibbin JA; Dowding C; Matutes E; Tindle R; Goldman JM
    Br J Haematol; 1986 May; 63(1):187-98. PubMed ID: 3011059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa.
    Miyazaki H; Inoue H; Yanagida M; Horie K; Mikayama T; Ohashi H; Nishikawa M; Suzuki T; Sudo T
    Exp Hematol; 1992 Aug; 20(7):855-61. PubMed ID: 1628703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
    Gronthos S; To LB; Haylock DN; Juttner CA
    Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of murine bone-marrow-derived granulocyte-macrophage colony-forming cells.
    Williams DE; Straneva JE; Shen RN; Broxmeyer HE
    Exp Hematol; 1987 Mar; 15(3):243-50. PubMed ID: 3817051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).
    Marley SB; Lewis JL; Scott MA; Goldman JM; Gordon MY
    Br J Haematol; 1996 Nov; 95(2):299-305. PubMed ID: 8904885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of human bone marrow cells in density gradients of polyvinylpyrrolidone coated silica gel (Percoll).
    Olofsson T; Gärtner I; Olsson I
    Scand J Haematol; 1980 Mar; 24(3):254-62. PubMed ID: 6246570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia.
    Blackburn MJ; Wheldon TE; Field SB; Goldman JM
    Br J Cancer; 1984 Dec; 50(6):745-51. PubMed ID: 6594154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.